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Passive ventricular remodeling is defined by the process of molecular ventricular
adaptation to different forms of cardiac pathophysiology. It includes changes in tissue
architecture, such as hypertrophy, fiber disarray, alterations in cell size and fibrosis.
Besides that, it also includes molecular remodeling of gap junctions, especially those
composed by Connexin43 proteins (Cx43) in the ventricles that affect cell-to-cell
propagation of the electrical impulse, and changes in the sodium channels that modify
excitability. All those alterations appear mainly in a heterogeneous manner, creating
irregular and inhomogeneous electrical and mechanical coupling throughout the heart.
This can predispose to reentry arrhythmias and adds to a further deterioration into
heart failure. In this review, passive ventricular remodeling is described in Hypertrophic
Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Ischemic Cardiomyopathy (ICM),
and Arrhythmogenic Cardiomyopathy (ACM), with a main focus on the heterogeneity of
those alterations mentioned above.
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INTRODUCTION
The lifelong purpose of the heart is maintenance of cardiac output
and supply of all organs with an appropriate amount of oxygen
and nutrients. At the same time it steers the controlled home-
ostasis of the blood via clearance of waste products, drugs and
imbalanced levels of ions and proteins in the lungs, liver, and
kidneys. To be able to fulfill this task, the heart has to adapt
its workload to the needs of the body (Kemp and Conte, 2012).
Many different diseases like coronary artery disease, myocardial
infarction, hypertension, dysfunction of valves, congenital heart
disease, lung diseases, diabetes, anemia, hyperthyroidism, and or
arrhythmia/dysrhythmia can alter the performance of the heart
(Lloyd-Jones et al., 2002; van Rijen et al., 2006; Roger et al., 2011).
In order to preserve cardiac output under these conditions, the
heart will start several compensatory mechanisms, like the Frank
Starling mechanism, neurohumoral activation, and inflamma-
tional responses (Westerhof and O’Rourke, 1995; Lee and Tkacs,
2008). Moreover, the heart starts to modify the gene program
that shapes the individual cells that compose the organ. This in
an attempt to adapt chronically to the new requirements of its
environment. These adaptations together will result in myocar-
dial remodeling that most often has heterogeneous characteristics
(Swynghedauw, 1999).
By nature, the heart itself is a rather heterogeneous organ:
morphologically, the right and left side as well as atria and ventri-
cles show various differences in cell constellations, hemodynamics
and their respective electrical characteristics (Zimmer, 1994). The
different resistances in peripheral and pulmonary circulation for
instance are causative for the differences between left and right
ventricle anatomy (right ventricular wall is much thinner than the
left wall). Also with respect to molecular make-up and microar-
chitecture of the cardiac muscle significant differences exist. The
way the fibers are orientated within the left and right ventricle
is not comparable. Electrical impulse propagation faces differ-
ences in conduction velocity between left and right ventricles
but also with the specialized conduction system. Part of that
relies on differences in expression level and pattern of gap junc-
tion channels and the ion channels that underlie action potential
generation.
The sodium channel protein Nav1.5, for instance, is hetero-
geneously distributed throughout the ventricles and the cardiac
conduction system in healthy hearts (Remme et al., 2009). Besides
that, two pools of Nav1.5 channels can be found in cardiomy-
ocytes: a lateral pool and a pool in the intercalated disc that co-
exist and interact with different proteins (Petitprez et al., 2011).
Also Cx43 is found in different densities within the healthy heart
e.g., regarding the posterior and anterior wall of the ventricles
(Strom et al., 2010).
Beyond the natural heterogeneity that is found under the nor-
mal physiological functioning of the heart, this review will focus
on the heterogenic aspect that is involved in passive remodel-
ing of the ventricles under pathophysiological conditions. Passive
remodeling is defined as the chronic molecular and structural
adaptations in ventricular cardiomyocytes and alterations in gene
expression as induced by different forms of heart disease. Active
remodeling, in contrast, is defined as phosphorylation processes
that e.g., result from sympathic and parasympathic imbalance.
This is exampled by the increase in heart rate that is facilitated
www.frontiersin.org December 2014 | Volume 5 | Article 482 | 1
Kessler et al. Heterogeneous remodeling in cardiac disease
through alterations in phosphorylation of ion channels (e.g.,
L–type calcium channels) in the sinus node.
One of the most crucial and maladaptive factors of passive
remodeling in the ventricles is heterogeneity in electrical and
structural remodeling. In that perspective we will discuss fac-
tors associated with conduction and propagation of excitation,
but not with respect to repolarization (e.g., potassium currents,
heterogeneity in action potential duration), and contraction (e.g.,
calcium-handling and sarcomeric proteins). During remodeling,
heterogeneous alterations in three factors contribute to increase
the propensity to arrhythmias and to develop heart failure: (1) tis-
sue architecture such as hypertrophy, fibrosis, fiber disarray, and
cell size, (2) electrical coupling by means of gap junctions and
especially those composed of Cx43, and (3) electrical excitabil-
ity due to changes in sodium channels that are mainly composed
of Nav1.5 (Kleber and Rudy, 2004; van Rijen et al., 2006; Bowers
et al., 2010).
We will address remodeling of these factors during Dilated
Cardiomyopathy (DCM), Hypertrophic Cardiomyopathy
(HCM), Ischemic Cardiomyopathy (ICM) and Arrhythmogenic
Cardiomyopathy (ACM), previously known as Arrhythmogenic
Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D). In
general, DCM can be identified by cardiac chamber dilatation
and reduced systolic function often leading to congestive heart
failure. It is the most commonly occurring cardiomyopathy in
adults and children and is associated with muscle dysfunction
and/or volume overload. On the other hand, in children DCM
is mostly caused by myocarditis and neurohumoral diseases
(Towbin et al., 2006). DCM is defined as the presence of left ven-
tricular fractional shortening (<25%) and/or LVEF < 45% and
left ventricular end-diastolic dimensions (LVEDD) of >117%
of the predicted value by the Henry formula (Mestroni et al.,
1999). It can also be caused by a variety of genetic mutations
that are uncovered upon analysis of family history and molecular
genetic testing. These forms, however, are referred to as familial
dilated cardiomyopathy (FDC) (Hershberger and Morales, 2013).
HCM has been defined by the World Health Organization as the
presence of left or biventricular hypertrophy, in absence of any
cardiac or systemic cause (Richardson et al., 1996). When this
definition is used, the general prevalence is about 1:500 (Maron,
2002). However, HCM can also be caused by mutations in genes
encoding for cardiac sarcomeric and myofilament proteins;
for the latter already more than 1400 mutations have been
identified increasing the prevalence even more (Maron et al.,
2012; Efthimiadis et al., 2014).
ICM results from myocardial ischemia and is characterized by
remodeling due to myocardial infarction which eventually trig-
gers loss of contractility, still being the leading cause of ventricular
dysfunction worldwide (reviewed in Wu, 2007).
Finally, ACM is a non-ischemic progressive and predominantly
heritable heart disease associated with cardiac arrhythmias and
sudden cardiac death (Corrado et al., 2000). ACM is character-
ized through replacement of cardiomyocytes by fibro-fatty tissue
(Thiene et al., 1988; Saffitz et al., 2009). About 60% of the cases
have a hereditary basis and mutations causing ACM have been
found in several desmosomal genes like desmoplakin (Rampazzo
et al., 2002), plakoglobin (Asimaki et al., 2007), plakophilin2
(Gerull et al., 2004; van Tintelen et al., 2006), desmocollin2
(Heuser et al., 2006; Syrris et al., 2006), and desmoglein (Pilichou
et al., 2006). Moreover, genes not related to the desmosome can
be affected such as the transmembrane protein 43 (TMEM43),
phospholamban (PLN), desmin and transforming growth factor
beta3 (TGFβ3) (Beffagna et al., 2005; Merner et al., 2008; Otten
et al., 2010; van der Zwaag et al., 2012).
In addition, a variety of mutations in several ion channels that
add to action potential generation have been described to trigger
pro-arrhythmic remodeling of the heart. This subset of arrhyth-
mogenic cardiac diseases is, however, beyond the scope of this
review.
TISSUE ARCHITECTURE
Several extrinsic and intrinsic factors can lead to alterations in
cardiac workload. Those changes can trigger growth of individual
myocytes leading to cardiac hypertrophy. An increased amount of
hypertrophy is associated with a decreased conduction velocity of
the electrical impulse (Winterton et al., 1994; Cooklin et al., 1997;
McIntyre and Fry, 1997). Moreover, metaplasia of fibroblasts
into myofibroblasts, a more contractile and collagen producing
cell type can increase the deposition of the extracellular matrix
(ECM) leading to fibrosis (Davis andMolketin, 2013). This is fur-
ther supported by an increased rate of cell death—necrosis and
apoptosis—and inflammatory processes such as the secretion of
TNF-alpha or IL-6 (Gill et al., 2002; Nian et al., 2004). Besides
that, also alterations in myocardial fiber orientation can impor-
tantly affect characteristics of cardiac impulse propagation (Vetter
et al., 2005).
HYPERTROPHY AND CELL SIZE
The key feature of hypertrophy in general is an increased cell
size that electrically can be measured as an increase in cell-
capacitance. Hypertrophy and increased cell size counteract the
increased wall tension as caused by changes in cardiac workload
(Laplace’s law). Therefore, hypertrophy is seen as a compen-
satory mechanism. However, cardiac impulse propagation as well
as conduction velocity gradually decrease with increasing sever-
ity of hypertrophy (Winterton et al., 1994; Cooklin et al., 1997;
McIntyre and Fry, 1997) leading to an elevated risk for heart
failure and sudden cardiac death (Meyerburg et al., 1992).
In DCM mainly the cell length is increased and this is associ-
ated by dilation and systolic disturbances of predominantly the
left ventricle. Also both ventricles can be impaired, but gener-
ally with normal left ventricular wall thickness (Richardson et al.,
1996; DuPont et al., 2001). The effect of eccentric hypertrophy on
electrical signaling has been addressed in several animal models.
An increase in conduction velocity was shown in a rabbit model,
where a combined pressure- and volume overload increased heart
weight by about 100%, and both cell length and width were
increased by about 30%. Delayed activation was indicated by
an increase in QRS duration from 50ms in control to 58ms in
rabbits with DCM. Parallel and transverse to fiber orientation,
however, epicardial conduction velocity appeared increased by
18 and 16%, respectively while transmural conduction velocity
was unchanged. The authors of this study concluded that the
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increased cell size was responsible for the increase in longitudi-
nal and transverse conduction velocity. Moreover, they concluded
that the increased conduction velocity could not sufficiently com-
pensate for the increased heart size, which was causative for the
prolonged QRS durations (Wiegerinck et al., 2006). In a dog
model of rapid pacing, it has been shown that QRS duration and
cell length were increased, while cell width was reduced. Besides,
transmural conduction velocity was reduced in both RV and LV,
while Cx43 expression was reduced only in LV. As such, reduced
cell width seems to play a dominant role in the reduced conduc-
tion velocity (Akar et al., 2004). In mice models, where DCM
was induced by transverse aortic constriction (TAC), cell size,
and the amount of hypertrophy was significantly increased after
6 weeks of TAC. This was leading to prolongations of PQ, QT,
and QRS intervals, and slowing of right ventricular conduction
velocity parallel to the fiber orientation (Boulaksil et al., 2010b).
Data of a recent study with DCM patients showed elevated lev-
els of myosin light-chain kinase and CRP that could possibly
serve as diagnostic biomarkers for hypertrophy (Branishte et al.,
2013).
In HCM, primarily cell width is increased (Formigli et al.,
2003) leading to hypertrophy without dilation of the ventricles
(Maron, 2002). This affects conduction of the electrical impulse
as has been shown using computer modeling, where conduction
velocity increased with cell size, and cell size was determined to
be the dominant factor affecting conduction velocity (Spach et al.,
2000). Also for HCM, several animal models have been described.
In a rat model, where RV-HCM was induced by injections with
monocrotaline (leading to pulmonary hypertension), increased
cell width and lateralized Cx43 expression were found, while cell
length was unaffected. Conduction velocity parallel to the fiber
orientation was decreased, although perpendicular to the fiber
orientation the conduction velocity was unchanged (Uzzaman
et al., 2000). Similar results were obtained in another study that
used the same rat model with monocrotaline induced pressure
overload. In this study, RV cell width was increased, but again cell
length remained unaffected. In the left ventricle, cell width and
length were both decreased. Moreover, longer action potentials
(at 90% repolarization), prolongation of the effective refrac-
tory period, and slowing of the longitudinal conduction veloc-
ity occurred (Hardziyenka et al., 2012). Besides the rat model,
LV epicardial mapping was also performed in patients after
chronic thromboembolic pulmonary hypertension. Comparable
to the experimental model, these patients also showed prolon-
gation of the effective refractory period and conduction slowing
(Hardziyenka et al., 2012).
In ICM, cardiac hypertrophy can be found in the major-
ity of patients (Kannel et al., 1961; Zaino and Tabor, 1963).
In MRL (Murphy Roths Large) mice exhibiting an ICM phe-
notype, increased cell size and hypertrophy lead to a faster
progression toward heart failure than in controls (Smiley et al.,
2014). Moreover, electrocardiographic left ventricular hypertro-
phy embedded a predictive value for arrhythmias and mortality
in ICM patients, making it an important factor to consider dur-
ing diagnosis (Bender et al., 2012). In ACM no gross cardiac
hypertrophy has been reported and the individual cell size is
not increased either. Therefore, hypertrophy is not included as a
parameter into the revised Task Force Criteria that are used to
diagnose ACM (Marcus et al., 2010).
FIBROSIS AND MYOCARDIAL FIBER DISARRAY
In the healthy heart, cardiac myocytes are embedded in the ECM,
a network of multiple molecules, proteins and thin intertwin-
ing strands of collagen fibers, synthesized by cardiac fibroblasts
(Manabe et al., 2002). This network ensures tissue strength
and allows cell-cell contact between neighboring cells (Weber
et al., 1994). Cardiac fibrosis is the inappropriately high amount
of collagen deposition in the heart during pathophysiological
remodeling which hampers electrical conduction and enables the
development of arrhythmias (Krenning et al., 2010). In addition,
also cardiomyocyte fiber orientation plays an important role in
the propagation of the electrical signal and fiber disarray can fur-
ther facilitate the generation of ventricular arrhythmias (Brugada
et al., 1991; Punske et al., 2005) This was recently shown in a
study that combined data from neonatal rat cardiomyocytes and
computer models (Kudryashova et al., 2014).
Fibrosis can be divided into replacement fibrosis (com-
pact and patchy) and reactive fibrosis (interstitial and diffuse)
(Swynghedauw, 1999). Typical examples of these four differ-
ent forms we published before and are expressed in Figure 1
of a review article by the de Jong et al. (2011). Replacement
fibrosis occurs after clearance of dead myocytes, where cardiac
cells will be replaced by collagen fibers facilitating the preser-
vation of the structure of the myocardium as well as the clear-
ance of debris (de Jong et al., 2011). This normally includes
compact or patchy fibrosis that is generated after an infarct
or in due to chronic pressure overload. These processes have
been described both in patients and in experimental animal
models (Xia et al., 2009). Compact fibrosis is created, when a
whole area is replaced by fibrosis and no viable myocytes are
left. Although this seems to be dramatic for the cardiac con-
tractile performance, this form is the least arrhythmogenic (de
Bakker et al., 1988). Patchy fibrosis describes areas, where fibro-
sis and myocardial cells are confounded. In this case, collagen
fibers are long strands disturbing the electrical signal propagation
(de Bakker et al., 1993). Reactive fibrosis describes the process
when more collagen is produced than degraded without a loss
of viable cardiomyocytes. This includes interstitial and diffuse
fibrosis and can be caused by mutations and changes in gene
expression, a phenotypical switch from fibroblasts into myofi-
broblasts, as well as due to aging (Biernacka and Frangogiannis,
2011). Interstitial fibrosis is localized in between the individual
cells. High interstitial collagen content causes reduced compli-
ance and electrical impairment (Rohr, 2009) possibly leading
to arrhythmias and heart failure (Janicki and Brower, 2002).
Diffuse fibrosis is comparable to patchy fibrosis, however, the
collagen strands are short and this form is less arrhythmogenic
(Kawara et al., 2001).
In murine animal models that can be followed and analyzed at
different time points after the experimental intervention has been
made, chronic pressure overload initially leads to reactive fibrosis
and in later stages this may change into a heterogeneous deposi-
tion of replacement fibrosis. The switch is likely caused by the fact
that at a certain time point proper nutrient supply to the cells fails
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FIGURE 1 | The cardiac gap junction. Gap junctions are located in the intercalated disc. They consist of two hemichannels (connexons) connecting across the
intercellular space. Each hemichannel is provided by one cell and connexons are composed of six hexagonally arranged connexin proteins.
to maintain a minimal level (Isoyama and Nitta-Komatsubara,
2002).
Myocardial fiber disarray is the result of altered fiber orien-
tation after e.g., an infarct. Adjacent cardiomyocytes are then
mostly aligned in a perpendicular way or obliquely to each
other in or around the collagen (Hughes, 2004). Nowadays,
predominantly computer models are used to simulate possible
alterations and effects on electrical propagation caused by fiber
disarray. Computer models are by definition artificial and simi-
larly to genetic engineered animal models, care should be taken
by extrapolating these results to the human heart. However, these
mathematical models may provide valuable additive insight, since
they allow studying the effects induced by individual alterations
but also the summation of more than one altered factor can be
studied systemically. With such models models, risk of cardiac
death can be predicted in e.g., long QT patients and various fac-
tors can be implemented at the same time like cell size, wall
thickness, action potential duration and fibrosis (Hoefen et al.,
2012; Zhao et al., 2013).
InDCMpredominantly patchy areas of interstitial and replace-
ment fibrosis can be found, but also perivascular patterns have
been described (Nakayama et al., 1987; Swynghedauw, 1999). In
HCM patients, interstitial fibrosis predominates (Swynghedauw,
1999). In mice with chronic pressure overload, next to hyper-
trophy, increased levels of interstitial fibrosis have been reported
in many cases (Xia et al., 2009; Boulaksil et al., 2010a,b).
Moreover, myocardial disarray is one of the hallmarks of HCM
(Hughes, 2004). Although it is also present in other cardiac
diseases and even in physiologically aged hearts, through the
presence in high quantities it is specific for HCM making it
a highly sensitive and useful marker (Hughes and McKenna,
2005).
In ICM, infarcted myocytes are replaced predominantly by
heterogeneously distributed replacement- and interstitial fibro-
sis creating islands of cardiomyocytes surrounded by scar tissue.
This so-called “labyrinth” of viable strands of cardiomyocytes
surrounded by insulating areas of fibrosis creates disconnec-
tion of myocytes that leads to excitation blocks and arrhythmias
(Fenoglio et al., 1983; Weber et al., 2008). In murine infarct mod-
els, fiber disarray has been reported in the infarct border zone,
although to a much lesser extent than in HCM (Smith et al.,
1991).
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ACM is characterized by degeneration of cardiomyocytes
and fibro-fatty replacement (Thiene et al., 1988). One theory
is that altered cell-cell adhesion due to mutations in genes
encoding for structures of the intercalated disc, e.g., the desmo-
somes, causes injuries to myocytes. This promotes cell death and
leads to replacement by fibro-fatty tissue (Saffitz et al., 2009).
Histologically, analysis of fibrosis and fiber orientation can help
to diagnose any of the above described diseases. Moreover, in all
diseases, fibrosis leads to conduction blocks, which increases the
propensity to develop reentry arrhythmias, or promotes the man-
ifestation of ectopic impulse generation in relatively uncoupled
clusters of cardiomyocytes due to disease-induced remodeling of
the expressed ion channels.
ELECTRICAL COUPLING—GAP JUNCTIONS
Gap junctions in the heart are agglomerates of channels that
connect the cytoplasm of two adjoining cells allowing electri-
cal coupling between the cardiomyocytes as well as the exchange
of certain small molecules, metabolites and ions up to a size
of approximately 1 kDa (Elfgang et al., 1995; Noorman et al.,
2009). One gap junction channel consists of two hemi-channels
(connexons), each delivered by one of the two adjoining cells
(Figure 1). The two connexons dock in the intercellular space to
form a functional channel.
The connexons are composed of connexin proteins. In car-
diomyocytes the three main isoforms that are expressed are
Connexin 40 (Cx40), Connexin 45 (Cx45), and Connexin 43
(Cx43) with Cx43 being predominant in ventricular cardiomy-
ocytes. Together with adherens junctions and desmosomes, gap
junctions are localized in the intercalated disc (ICD), a step-
like specialized membrane structure at the longitudinal cell edges
between two cells (Figure 2). In those ICD’s, gap junctions are
normally present in the regions parallel (interplicate) to the
longitudinal axis of the cardiomyocytes (Smith et al., 1991).
In patients of all four types of cardiac disease, a reduction in
ventricular Cx43 localized at the ICD has been found (Peters et al.,
1993; DuPont et al., 2001; Kaplan et al., 2004a). Using genetically
engineered animal models, a plethora of data have been collected
regarding to role of Cx43, using Cx43 knock out animal mod-
els. In 1995, the first Cx43 KO model revealed that these mice
died perinatally due to major heart problems (malformation of
the outflow tract) and cardiac failure (Reaume et al., 1995). Since
then, conditional Cx43 KO mice and haploinsufficient animals
have been generated. Nevertheless, results obtained from studies
with heterozygous KO animals are contradicting. Mice showed
reduced expression of Cx43 up to 50%, and in some studies
this reduction resulted in reduced conduction velocity (Guerrero
et al., 1997; Thomas et al., 1998; Eloff et al., 2001) while other
FIGURE 2 | The intercalated disc (ICD). The intercalated disc is the region between two cardiomyocytes, where different junctions are located: Gap junctions,
adherens junctions, and desmosomal junctions as well as ion channels. They all form macromolecular protein complexes with different functions.
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studies in which a similar reduction in Cx43 was achieved no
alterations in conduction velocity were reported (Morley et al.,
1999; van Rijen et al., 2004; Stein et al., 2009, 2011). These
contradicting results triggered to invent a different approach to
reduce Cx43 expression, and also to circumvent the problem
of perinatal death in homozygous KO mice. This was achieved
through generation of two conditional KO mice models (Orban
et al., 1992).
In the first model, one coding region of the Cx43 gene
was replaced by the fusion construct Cre-ER(t) and the other
Cx43 allele was flanked by loxP (Feil et al., 1996) resulting
in a 50% reduced expression of Cx43 under basic conditions
(Cx43CreER(t)/fl). Exposure to an agent activating the Cre recom-
binase (e.g., Tamoxifen) resulted in a further reduction of Cx43
expression up to maximally 95% (van Rijen et al., 2004). In the
second model, the Cre gene was placed behind an alpha-myosin-
heavy-chain (αMHC) promoter resulting in the deletion of the
floxed Cx43 gene (αMHC-Cre/Cx43fl/fl) once the promoter got
activated (Gutstein et al., 2001). In this way, the Cx43 gene was
knocked out around birth allowing those animals to develop nor-
mally during gestational stages. In both models, mice died due to
arrhythmias. In the case of the αMHC-Cre/Cx43fl/fl mice death
occurs around 1 or 2 months after birth (Gutstein et al., 2001)
and in the case of the Cx43CreER(t)/fl mice within 1 month after
induction of the deletion (Eckardt et al., 2004).
In cell cultures of neonatal mouse cardiomyocytes with genet-
ically reduced levels of Cx43, no differences in action poten-
tial amplitude or minimum diastolic potential could be found
compared to wild type cells. However, dV/dtmax and action
potential duration was increased (Thomas et al., 2003). Also
intercellular conductance was reduced and propagation was
slower and highly discontinuous (Beauchamp et al., 2004).
In tissue strands composed of these cells and wild type
cells, propagation velocity decreased significantly, when the
amount of wild type cells was less than 50%. Again, excitation
between wild the two types of cells was highly discontinuous
(Beauchamp et al., 2012).
In humans, DCM is linked to a reduced expression of Cx43,
especially seen together with lateralization (Kitamura et al., 2002,
2003; Kostin et al., 2003; Salameh et al., 2009). In animal models
this observation was confirmed repeatedly. In mice with forced
retinoic acid signaling (Hall et al., 2000), Cx43 expression was
reduced and lateralized, with in one study some upregulation
of Cx40 in the ventricles (van Veen et al., 2002). This led to
an increase in QRS duration, a reduction in conduction velocity
and an increased spatial dispersion of conduction velocity (Hall
et al., 2000; van Veen et al., 2002). Cx43 downregulation was
also confirmed in mice with a knock-out of muscle LIM protein
(an acronym of the three gene products Lin-11, Isl-1 and Mec-3)
(Ehler et al., 2001), and in a guinea pig model of chronic pres-
sure overload (Wang et al., 1999). However, in another mouse
model with longstanding pressure overload, no reductions in
total Cx43 could be observed, but 44% of the animals displayed
arrhythmias (Boulaksil et al., 2010a). In a rabbit DCM model
of a combined volume and pressure overload, reduced mid-
myocardial Cx43 was reported, QRS duration was prolonged and
arrhythmias were inducible (Wiegerinck et al., 2006). Besides this
animal model, another DCM rabbit model induced by volume
overload showed a reduction in Cx43 expression in different
groups (Goldfine et al., 1999; Haugan et al., 2006). In a dogmodel
of DCM (induced by RV pacing), lateralized Cx43 expression was
described and immunofluorescent signals were decreased in the
left ventricle, but not in the right. Moreover, arrhythmias could
be induced and QRS duration was prolonged. This was associated
with a reduced longitudinal and transversal conduction velocity
in both LV and RV (Akar et al., 2007). It was also reported that
downregulation of Cx43 triggered fibrosis formation after pres-
sure overload thereby connecting the different passive changes in
the heart (Jansen et al., 2012a). The latter study showed that the
severity of fibrosis could directly be related to the amount of Cx43
downregulation.
In HCM patients, in an early stage of the disease, an initial
increase in Cx43 expression was described together with extensive
lateral staining. In later stages, Cx43 was reduced and heteroge-
neously distributed (Kostin et al., 2004). Other groups showed
a reduction in Cx43 without lateralization, or even lateraliza-
tion without changes in Cx43 expression levels (Peters et al.,
1993; Sepp et al., 1996). Animal models confirm some of the
observed changes in humans. As already described in the hyper-
trophy section, in a rat model where HCM was induced using
monocrotaline, a decrease in Cx43 expression at the ICD with
lateralization was shown (Uzzaman et al., 2000) resulting in a,
reduced longitudinal conduction velocity. The transverse con-
duction velocity and also cell width were unaltered. The reduced
longitudinal conduction velocity was probably not caused by the
overall diminishing of Cx43, because normally mild changes in
coupling do not affect conduction velocity. Moreover, increased
lateral expression of Cx43 and hypertrophy did not sufficiently
lower resistance perpendicular to the fiber orientation to alter
transversal conduction velocity (Palka et al., 1997; Jongsma and
Wilders, 2000; Gutstein et al., 2001; van Rijen et al., 2004).
More likely the altered source/sink ratios due to the changed
axial/perpendicular resistance ratio might have influenced the
conduction velocity. In another rat model, where chronically ele-
vated pulmonary pressure triggered development of HCM, the
overall amount of Cx43 remained the same, but it was heteroge-
neously distributed (Sasano et al., 2007). In two different rabbit
models of HCM (one with a mutation in troponin 1 and one
with the beta-MyHC-Q403 mutation), a significant increase in
total mid-myocardial expression of Cx43 has been described,
including phosphorylated Cx43 (Sanbe et al., 2005; Ripplinger
et al., 2007). In an UM-X7.1 cardiomyopathic hamster model
of HCM (leading to loss of cytoskeletal delta-sarcoglycan pro-
tein and therefore to cardiac remodeling, failure, and mortality)
hypertrophy, a decrease in Cx43 mRNA, increased amounts of
fibrosis and arrhythmias were seen after 20 weeks (Ambra et al.,
2002; Sato et al., 2008). Cardiac hypertrophy and heart failure can
also be induced by overexpression of constitutively active form of
cardiac calcineurin-A (CnA) in the mouse heart. Next to hyper-
trophy these mice develop rapidly after birth extensive amounts
of fibrosis and show a high incidence of arrhythmias (Molkentin
et al., 1998). In this model reduced Cx43 signals in the ICD’s
and decreased conduction velocity can be observed (Bierhuizen
et al., 2008). In mice undergoing TAC, heterogeneous and partly
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reduced signals of Cx43 have been reported leading to dispersed
impulse conduction (Boulaksil et al., 2010a,b).
In ICM, ischemia reduces gap junction permeability (Dhein,
2006) and induces lateralization of Cx43 (Peters et al., 1993;
Beardslee et al., 2000). The infarct border zone (the region bor-
dering healthy and infarcted tissue) will, in that respect, be most
at risk of remodeling. Already in 1991, Smith et al. reported
gap junction remodeling in this zone, including reduced and
lateralized Cx43 signals (Smith et al., 1991). This was also con-
firmed in dogs (Peters et al., 1997; Huang et al., 1999; Cabo
et al., 2006), and patients (DuPont et al., 2001). In patients, alter-
ations were even detected at areas distant from the border zone
(Kostin et al., 2003). Moreover, an upregulation in Cx45 could be
observed in the border zone, resulting in reduced gap junctional
communication due to the intrinsic different properties of the
Cx45 gap junction channels (Yamada et al., 2003). The observa-
tion of reduced and heterogeneously distributed Cx43 could also
be confirmed in rabbit models (Tansey et al., 2006). However, in
transgenic mice with 50% of the normal Cx43 expression level,
the post-infarction area was smaller than in controls (Kanno et al.,
2003). This would suggest that preservation of Cx43 is not per
se beneficial for maintenance of function of the infarcted heart.
Zhang et al. (2010) even proposed to be careful with increasing
Cx43 expression in heart diseases until the meaning of alterations
in expression of Cx43 upon myocardial infarction is fully under-
stood. We have to keep in mind, however, that Cx43 gap junction
channels not only are responsible for propagation of the electrical
impulse in the heart, but also for metabolic coupling of the car-
diomyocytes. In that respect, a smaller infarct size might rely on a
reduced spreading of pro-apoptotic death signals due to a reduced
level of intercellular coupling.
In ACM, reduced Cx43 expression has been reported in several
studies. Theories are that Cx43 remodeling is triggered by abnor-
mal mechanical coupling (Kaplan et al., 2004a) due to mutations
in proteins composing junctions that support the structure of the
cardiomyocytes. The different junctions in the intercalated disc
assemble and form clusters. Therefore, dysfunction of one junc-
tion/protein influences the functioning of others (Agullo-Pascual
et al., 2014). In human studies, heterogeneous disturbances in
Cx43 signals, decreased presence in the intercalated disc, and
lateralization of the signal has been reported in all different
forms of ACM (Kaplan et al., 2004a; Noorman et al., 2013a).
Although previously thought that this would predominantly be
in the right ventricle, these changes are not exclusive and can
also be found in the left ventricle and the septum (Noorman
et al., 2013b). In general, this leads to scattered impulse conduc-
tion, which increases the susceptibility to arrhythmias (Boulaksil
et al., 2010a). In the first attempts to investigate ACM in animal
models, PKP2 mutations (the most abundant mutated desmoso-
mal protein in humans) were used. In mice, homozygous null
mutations in PKP2 are lethal whereas heterozygous mutations
do not show any or only little phenotype (Ruiz et al., 1996;
Grossman et al., 2004). Therefore, it is suggested that the abun-
dant phenotypical presentation of ACM in patients is, on top
of the genetic mutation, dependent on additional factors (e.g.,
inflammation, exercise). To study the familial cases, initially, two
different familial forms of ACMhave been studied withmutations
in desmosomal genes different from PKP2: Naxos disease [muta-
tion in plakoglobin (PKG)] (Protonotarios et al., 1986; McKoy
et al., 2000; Protonotarios and Tsatsopoulou, 2004); and Carvajal-
syndrome [desmoplakin (DPK)] (Carvajal-Huerta, 1998; Norgett
et al., 2000). In patients, in both diseases, Cx43 is reduced in
both ventricles in the early phase of the disease and an increase
in non-phosphorylated Cx43 was detected that might be asso-
ciated with accelerated down-regulation of the protein (Kaplan
et al., 2004a,b). An in vitro model for Naxos disease using neona-
tal rat cardiomyocytes transfected with an adenovirus encoding
the PKG 2057del2 mutation recapitulated all abnormalities seen
in patients: reduced plakoglobin and Cx43 signal at the ICD’s,
increased apoptosis and secretion of inflammatory mediators
(Asimaki et al., 2014). Moreover, a zebrafish model with the same
mutation was used to screen for potential drugs to intervene
with the development and progression of ACM (Asimaki et al.,
2014). This latter study revealed promising results for future ther-
apy since disease-causing targets could be identified and in vitro
studies showed prevention and even regression of the disease
when the intervention was applied in the early phases of cardiac
remodeling.
EXCITABILITY
Proper contraction of the heart also results from a finely tuned
impulse generation, which feeds propagation. In ventricular
cardiomyocytes, action potential generation is initiated by the
fast and robust depolarization as caused by the opening of
the voltage-dependent Na+ channels (Clancy and Kass, 2002).
Already in 1921, Daly and Clark (1921) showed in frogs that rate,
propagation velocity and force of the cardiac contraction were
reduced in solutions containing a reduced (extra-cellular) sodium
concentration.
The human sodium channel consists of one alpha and four
beta subunits. The alpha subunit consists of four homologous
domains connected by cytoplasmic linkers (Figure 3). Each of
those domains consists in turn of six transmembrane sequences
(Balser, 1999). In cardiomyocytes two different pools of Nav1.5
channels co-exist, namely at the lateral membranes where the
channel interacts with the dystrophin-syntrophin complex and in
the intercalated disc where it binds SAP97 (Figure 2) (Petitprez
et al., 2011). Both pools are thought to interact with different pro-
teins. At the ICD, it is envisioned that Nav1.5 can influence e.g.,
Cx43 in the gap junctions and vice versa (Delmar, 2012).
Initially, much work on excitability has been performed in
vitro using neonatal rat cardiomyocytes. Lateron, in vivo experi-
ments on reduced excitability have been performed in genetically
engineered mice models. SCN5a haploinsufficient mice showed
about a 50% reduction of sodium current, while having a normal
survival rate (Papadatos et al., 2002). ECG analysis showed a pro-
longed RR interval, P-wave duration, PR interval, QRS duration,
and QT interval together with an age related aggravation of the
phenotype (Royer et al., 2005). In those SCN5a haploinsuffient
mice, QRS prolongation and conduction slowing was observed.
However, in young mice, epicardial conduction velocity was not
reduced in the left ventricle and only mildly reduced in the right.
The reduction in conduction velocity became more dominant
in both ventricles in older mice (12–17 months) where it was
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FIGURE 3 | The alpha subunit of the human sodium channel. The alpha
subunit of the human sodium channel consists of four homologous domains
connected by cytoplasmic linkers. Each domain is composed of six
trans-membrane sequences. G, glycosylation; P, phosphorylation; S, ion
selectivity; I, inactivation sites. Positive (+) charges in S4 are crucial for
transmembrane voltage sensing.
associated with increased fibrosis and altered Cx43 expression
(van Veen et al., 2005).
In patients with the 1795InsD mutation in the SCN5a gene,
bradycardia, conduction delay, QT prolongation, and right pre-
cordial ST-elevation can be detected. To investigate the cause
of sodium channel related diseases, and in particular the above
mentioned one, Remme et al. created a 1798InsD mouse model
(1798InsD is the mouse analog of 1795InsD in human), where
indeed a single mutation leads to a phenotype of bradycar-
dia, right ventricular conduction slowing, and QT prolongation
(Remme et al., 2006). Given the enormous amount of sodium
channel mutations leading to a pro-arrhythmic phenotype in
patients, generation of such mouse models significantly has con-
tributed to a better understanding of the underlying etiology. In a
DCM dog model, in which disease was induced through RV pac-
ing, neither sodium current density, nor upstroke velocity of the
action potential in left ventricular endo- or epicardial myocytes
differed from control individuals (Kaab et al., 1996; Akar et al.,
2004). Similarly, in a DCM rabbit model, sodium current den-
sity did not differ from controls in left ventricular myocytes
(Wiegerinck et al., 2006). Recent data from a Torsade de Pointes
sensitive canine heart model after chronic AV block (CAVB) con-
firm that no changes in INa appear, although increased cell size
was reported (Boulaksil et al., 2011).
HCM patients showed increased CaMKII phosphorylation of
Nav1.5 channels, which is in general associated with a delayed
inactivation of the current (Wagner et al., 2006; Coppini et al.,
2013). Increased late sodium current leads to prolonged repo-
larization (and therefore an increased action potential duration)
and arrhythmias as has been shown in patients and several animal
models (Jelicks and Siri, 1995; Undrovinas et al., 1999; Gray et al.,
2001; Mészáros et al., 2001; Coppini et al., 2013). Increased late
sodium current also causes changes in calcium metabolism and
homeostasis, influencing cell metabolism and contractile func-
tioning of the cells. This in turnmay lead to hypertrophy (Coppini
et al., 2013). In mice with calcineurin-induced cardiac hypertro-
phy, reduced Nav1.5 protein and RNA amounts could be found
in the ICD’s (Bierhuizen et al., 2008).
ICM is also associated with increased late INa (Ju et al., 1996;
Huang et al., 2001). Various causes can lead to an increase of
intracellular sodium concentration in ischemic cardiomyocytes.
First, ischemia seems to increase the amplitude of the late INa
significantly (Hammarstrom and Gage, 2002). Anaerobic glycol-
ysis, due to lack of sufficient oxygen supply to the cells, leads to
a decrease of ATP and leaking of protons via the cardiac Na/H
exchanger (NHE1). Because of that, more sodium enters the cell
(Tani and Neely, 1989). Moreover, a reduction of Na+/K+ ATPase
pump activity will cause an additional decrease of sodium extru-
sion (Xiao and Allen, 1999). Increased sodium levels will activate
the Na/Ca exchanger. This, in turn, leads to an increased con-
centration of calcium in the cell and a reduction in intracellular
pH. The altered ion concentrations will lead to drastic changes
in cellular metabolism, signal transduction, electrophysiological
characteristics and contractile properties, probably leading to cell
damage and cell death (Silverman and Stern, 1994; Imahashi et al.,
1999; Allen and Xiao, 2002).
In the early stages of hypoxia, an increase in intracellular
sodium concentration was observed in rat hearts that returned
back to pre-infarction levels, when ischemia was of short duration
(Tani and Neely, 1989). When sodium is persistently elevated,
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the subsequent increased calcium levels may be prevented by late
sodium current inhibition through ranolazine (Soliman et al.,
2012). Moreover, a NHE1 inhibitor has been reported to show
cardio-protective effects after infarction in a rat model (Huber
et al., 2012). Although controversial results have been published
lateron about NHE1, it is still under investigation and thought to
be one of the most effective post-infarct treatments (Karmazyn,
2013). Next to adherens-, gap- and desmosomal junctions, also
ion channels are located in the ICD (Balse et al., 2012), and it
becomes more and more clear that in ACM alterations in sub-
cellular localization of sodium channels is importantly involved
in the consequences of cardiac remodeling. In patients, a reduced
localization of Nav1.5 in the ICD has been reported (Noorman
et al., 2013a). In cultured cardiomyocytes, the reduced expres-
sion of PKP2, caused a subsequent reduction in the sodium
current and a slower conduction velocity (Sato et al., 2009).
Besides that, loss of expression of Ankyrin-G, an important
protein that anchors the voltage-gated sodium channel, leads
to disturbances in PKP2 and Cx43 expression. The other way
around, loss of PKP2 causes a reduction in expression of Ankyrin-
G as well as of Nav1.5 (Sato et al., 2011), thereby confirming
the role of sodium channels in this disease. Besides that, in
zebrafish and neonatal rat cardiomyocytes containing the men-
tioned 2057del2 plakoglobin (related to Naxos disease), a marked
reduction in INa current density was observed (Asimaki et al.,
2014). In these neonatal rat cardiomyocytes, the immunofluo-
rescent Nav1.5 signal at the membrane was reduced, but total
cell content appeared unchanged (Asimaki et al., 2014). This
reduction in INa and consequently a reduced conduction veloc-
ity has also previously been shown in transgenic mice with a
desmoglein-2 mutation (Rizzo et al., 2012). Moreover, reduced
heterogeneous expression of Cx43 in conditional knockout mice
caused decreased expression of Nav1.5, reduced sodium current
and an increased vulnerability of those mice for arrhythmias
(Jansen et al., 2012a). Similarly, PKP2 haploinsufficiency in mice
resulted in a sodium current deficit and arrhythmogenesis when
triggered with flecainide (Cerrone et al., 2012). The importance
of these finding was reflected in a study of Cerrone et al. which
showed that in patients with a mutation in PKP-2, provocation
with flecainide triggered arrhythmias suggesting that also in these
patients a concomitant sodium current deficit existed (Cerrone
et al., 2014).
HETEROGENEITY
The natural mode of functional heterogeneity within the normal
cardiac performance is also of importance during heart disease.
Due to, e.g., pulmonary disease or aortic stenosis, different parts
of the heart are affected prior to the other, leading to hetero-
genic alterations that conflict with the natural organization. In
ACM, where disease-dependent changes often start in the right
ventricle, the left ventricle can remain relatively unaffected in
the early stages of disease. In an opposite fashion aortic steno-
sis will first remodel the left ventricle before right ventricular
involvement manifests. Differently, right ventricular remodeling
due to pulmonary hypertension might simultaneously trigger LV
remodeling (atrophy) due to a reduced filling (Hardziyenka et al.,
2012).
These different types of remodeling are part of various diseases
and are by definition heterogeneous, since all of those diseases
have different causes and therefore treatment options (Coronel
et al., 2013).
Cardiac remodeling deteriorating into heart failure most likely
depends on a combination of the mechanisms as described in
this article, and it is characterized by heterogeneous remodel-
ing of excitation-contraction coupling (Coronel et al., 2001; Lou
et al., 2011). Pathophysiological heterogeneity in cardiac tissue
sustains ventricular tachycardia, stabilizes reentry arrhythmias
and provides substrate for sustained tachycardia (Pazo et al., 2004;
Ripplinger et al., 2006).
Passive heterogeneous ventricular remodeling in the heart
is one of the most destructive features of cardiac remodeling
and every remodeling mechanism itself shows the worst out-
come, when occurring heterogeneously. In this article, several
mechanisms of passive remodeling have been described during
DCM, HCM, ICM and ACM. Passive remodeling of tissue archi-
tecture was investigated focusing on fibrosis, alterations in cell
size, hypertrophy and fiber disarray. Disturbances in electrical
coupling were discussed by describing changes in the distribu-
tion of the gap junction protein Cx43. Remodeling of electrical
excitability was studied using the sodium channel protein Nav1.5.
To summarize, different types of fibrosis occur in all of the
four discussed heart diseases and act as modulators of impulse
propagation ranging from conduction slowing, increased disper-
sion of conduction and even conduction block. Moreover, it can
alter the structure of the heart, e.g., alterations in cellular dimen-
sions, which is caused by modifications in molecular pathways
that control normal cellular physiology. As a consequence this
may lead to reductions in excitability and cell-to-cell conduc-
tion (Fenoglio et al., 1983; Kawara et al., 2001). Heterogeneously
distributed fibrosis can even create a “labyrinth” in the heart facil-
itating reentry arrhythmias (Engelman et al., 2010). Therefore,
this is considered to be worse than only local interstitial fibrosis
since it would be more difficult for electrical signals to propagate
though a labyrinth of fibrotic patches than only being obstructed
by single fibers (Kawara et al., 2001; Tanaka et al., 2007). This
idea was strengthened by a study where reduction of heteroge-
neous patchy fibrosis was one-on-one correlated to a reduction of
arrhythmias (Stein et al., 2010).
Hypertrophy can be detected in HCM and ICM. Changes in
cell size are the key features of HCM and DCM, whereby HCM
is characterized by an increase in cell width and DCM by an
increase in cell length. Myocardial fiber disarray mainly occurs
in HCM, where it is even used as a biomarker. It can also be
observed in ICM, but to a much lesser extend. Heterogeneously
distributed hypertrophy, myocardial fiber disarray and changes
in cell size can lead to alterations in impulse propagation and
conduction velocity causing disturbed signaling, deregulated con-
tractions, and eventually heart failure (Meyerburg et al., 1992;
Winterton et al., 1994; Cooklin et al., 1997; McIntyre and Fry,
1997). Pathophysiological heterogeneity in the sense of right vs.
left ventricles or atria can also worsen disease phenotype as is
classically illustrated by the fact that progressive LV dysfunction
eventually results in RV failure too with consequently, pulmonary
remodeling and edema (Chen et al., 2012).
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Heterogeneous distribution, de-phosphorylation and a reduc-
tion of Cx43 signals in the ICD are characteristics found in all
four different heart diseases. They are one of the key features of
ACM (Noorman et al., 2013a), but also occur in DCM, ICM,
and late stages of HCM. This can lead to a reduction in lon-
gitudinal and an increase in transverse conduction (reducing
the normal anisotropic mode of conduction) causing hetero-
geneous propagation (increased dispersion of conduction) and
arrhythmogenesis. At these places signaling (mechanical or elec-
trical) will be more difficult leading to de-regulated intercellular
coupling (Boulaksil et al., 2010a). The heterogeneous distribu-
tion of the different proteins and structures can be sub-divided
into macro and micro heterogeneity. Macro heterogeneity com-
pares the different regions in the heart, whereas micro het-
erogeneity is a measure for local heterogeneity (Jansen et al.,
2012a).
Changes in expression and distribution of the sodium chan-
nel protein Nav1.5 can also be seen in HCM, DCM, and ACM.
Homogeneous distribution of Nav1.5 throughout different parts
of the heart is crucial for normal conduction (Clancy and Kass,
2002) although functional expression levels differ between epi-
card, endocard, and conduction system (Remme et al., 2009).
Heterogeneous distribution, caused by a local increase or decrease
of sodium channels possibly facilitates arrhythmogenesis and
therefore heart failure, since the sodium current will be hampered
or fastened locally (Wagner et al., 2011; Shryock et al., 2013).
Although these heterogeneous maladaptations can have effects
when occurring alone, they are often found to trigger arrhythmias
and eventually heart failure due to a combination of simultane-
ous alterations in different factors. Therefore, great care should
be taken when investigating one single mechanism of remodel-
ing, since a heterogeneous adaptation of one mechanism can also
cause others to develop or are even linked to each other. This
concept is illustrated by several studies, which report a simula-
taneous downregulation and de-phosphorylation of Cx43, and
Nav1.5, (Stein et al., 2009; Jansen et al., 2012b; Noorman et al.,
2013a) and even link this combination to an increased deposition
of fibrotic materials (van Veen et al., 2005; Jansen et al., 2012a).
These studies example the complexity of cardiac remodeling dur-
ing pathophysiology in relation to the increase in propensity to
develop arrhythmias.
Regarding the future perspective of cardiac research, one
should focus on these connections between heterogeneous
changes in single factors within the heart that lead to the total pic-
ture of heterogeneous remodeling. This might unravel currently
unknown relationships between the various forms of maladapta-
tion and help to improve the search for treatment options. In a
study that was mentioned before, long term administration of the
antihypertensive drugs eplerenone or losartan in a mouse model
of extreme aging not only reduced the amount of interstitial- and
patchy fibrosis, but also preserved a homogeneous pattern of gap
junctional coupling. This preservation of the normal substrate for
conduction resulted in a significantly reduced amount of arrhyth-
mias (Stein et al., 2010). Beyond pharmacological interventions,
pacing strategies (like cardiac resynchronization therapy) that
aim to correct the abnormal sequence of activation, e.g., due to
bundle branch block or electrical remodeling, will provide further
future perspectives to improve performance of the remodeled
heart.
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